Allison Hulme
Director/Board Member at VENTYX BIOSCIENCES, INC.
Net worth: - $ as of 2024-03-30
Profile
Allison J.
Hulme is currently the President, Chief Executive Officer & Director at Aeovian Pharmaceuticals, Inc. She is also a Director at InteKrin Therapeutics, Inc. since 2013 and an Independent Director at Ventyx Biosciences, Inc. since 2023.
Previously, she served as the COO, Director & Head-Research & Development at Sophiris Bio, Inc. from 2016 to 2019.
She was also an Executive Vice President at Elan Corp.
Plc in 2005 and held the position of Principal at Glaxo Wellcome Plc.
From 1995 to 2005, she worked at Elan Pharmaceuticals LLC as the Executive Vice President & Head-Global Development.
Dr. Hulme obtained a doctorate degree from Cranfield University in 1988 and an undergraduate degree from the University of Luton in 1985.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VENTYX BIOSCIENCES, INC.
-.--% | 2024-04-10 | 0 ( -.--% ) | - $ | 2024-03-30 |
Allison Hulme active positions
| Companies | Position | Start |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Director/Board Member | 2023-01-10 |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Director/Board Member | 2012-12-31 |
Aeovian Pharmaceuticals, Inc.
 Aeovian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aeovian Pharmaceuticals, Inc. engages in the development of pharmaceuticals. It offers inhibitors for the treatment of rare and age-related diseases. The company was founded by Stelios T. Tzannis in 2012 and is headquartered in Novato, CA. | Chief Executive Officer | - |
Former positions of Allison Hulme
| Companies | Position | End |
|---|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | 2004-12-31 |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2004-12-31 |
| Glaxo Wellcome Plc | Corporate Officer/Principal | - |
| SOPHIRIS BIO | Chief Tech/Sci/R&D Officer | 2019-12-30 |
Training of Allison Hulme
| Cranfield University | Doctorate Degree |
| University of Luton | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VENTYX BIOSCIENCES, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
| Glaxo Wellcome Plc | Health Technology |
Sophiris Bio, Inc.
 Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA. | Health Technology |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Health Technology |
Aeovian Pharmaceuticals, Inc.
Aeovian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aeovian Pharmaceuticals, Inc. engages in the development of pharmaceuticals. It offers inhibitors for the treatment of rare and age-related diseases. The company was founded by Stelios T. Tzannis in 2012 and is headquartered in Novato, CA. | Health Technology |
- Stock Market
- Insiders
- Allison Hulme